Clinical Trial Update: Study to Evaluate the Long- Term Safety and Efficacy of Luspatercept in Subjects Who Received at Least One Dose of Luspatercept in the Compassionate Use Phase

View source ↗

Summary

Clinical trial update on the long-term safety and efficacy of luspatercept in subjects who received at least one dose during the compassionate use phase; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thalassemia Major

Drugs mentioned

• Luspatercept (luspatercept)

Snippet

Sponsor: Fondazione per la Ricerca sulle Anemie ed Emoglobinopatie in Italia | Conditions: Thalassemia Major | Status: ACTIVE_NOT_RECRUITING